Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 140 of 144 pages ‹ First  < 138 139 140 141 142 >  Last ›

HSL2192
Sponsorship, authorship and accountability
CMAJ 2001

HSL2278
Sterne J, Smith G.
Sifting the evidence -- what's wrong with significance tests?
BMJ 2001; 322:226-231
http://bmj.bmjjournals.com/cgi/content/full/322/7280/226?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Sterne+J&andorexactfulltext=and&searchid=1124938332664_18808&stored_search=&FIRSTINDEX=0&sortspec=relevance&resourcetype=1

HSL2345
Consumers' Association
Policy report: promotion of prescription drugs: public health or private profit?
Consumers' Association 2001

HSL2346
Eichner , R MAROONICK, T J.
A review of direct-to-consumer (DTC) advertising and sales of prescription drugs: does DTC advertising increase sales and market share?
Journal of Pharmaceutical Marketing & Management 2001; 13:(4):19-42

HSL2347
Mintzes B, Baraldi R .
Direct-to-consumer prescription drug advertising: when public health is no longer a priority
DES Action Canada 2001;

HSL2348
Rubin , Ph .
Pharmaceutical advertising as a consumer empowerment device
Journal of Biolaw & Business 2001; 4:(4):59-65

HSL2551
Mintzes B, Baraldi R.
Direct to Consumer Prescription Drug Advertising: When preventing harm is no longer a priority
: DES Action Canada 2001;
http://web.archive.org/web/20011217054640/http://www.web.net/~desact/anglais/anglais.html

HSL2554
Meek C.
2001;
www.rpsgb.org.uk/pdfs/dtcarep.pdf

HSL2568
Consumers ASSOCIATION, .
dtca alliances organisations
2001;

HSL2571
Canadian Medical Association
CMA Policy: Physicians and the pharmaceutical industry (Update 2001)
2001;
www.cma.ca/staticContent/HTML/N0/l2/where_we_stand/physicians_and_the_pharmaceutical_industry.pdf

HSL5445
Rai AK.
The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Univ Ill Law Rev 2001; 2001:(1):173-210

HSL7765
Baqir W, Maguire A.
Doctors' and pharmacists' attitudes to the use of sugar-free and sugar-containing medicines in the elderly
International Journal of Pharmacy Practice 2001; 9:(3):177-184

HSL7768
DTC debate
Irish Pharmacy Journal 2001; 79:(137-138):140

HSL7801
E-commerce in pharmacy: opportunity or threat?
Acta-Farmaceutica-Bonaerense 2001; 9:(3):8-9, 16

HSL7804
Adachi T, Hara H, Hirano K.
Students' awareness about practical training in community prescription pharmacy
Japanese Journal of Pharmaceutical Health Care and Sciences 2001; 27:(4):386-391

HSL7806
Barlas S.
FDA proposed ruling on package inserts
P-and-T 2001; 26:259

HSL7809
Do Dear Health Care Professional letters make a difference?
Hospital Pharmacy 2001; 36:928

HSL7810
McPherson D.
Sweet taste of success: Tom Greene has a sure fire prescription for smiles
Community Pharmacist 2001; 93:(2):20-22

HSL7845
Framework for Research and Evaluation into the Effects of Managed Care on the Pharmaceutical Marketplace: excerpts from the final report
Journal of Research in Pharmaceutical Economics 2001; 10:(4):235-266

HSL7890
Frenia KJ, Maves MD, Toscani MR.
Rx to OTC switching...issues and answers
ASHP Annual Meeting 2001; 58:

HSL8831
Brynner R, Stephens T.
Dark Remedy: The Impact Of Thalidomide And Its Revival As A Vital Medicine
New York: Basic Books 2001
http://www.perseusbooksgroup.com/basic/book_detail.jsp?isbn=0738205907

HSL16336
Cohen JS
Overdose : The case against the drug companies – Prescription drugs, side effects and your Health New York: Tarcher/Putnam 2001

HSL18002
Monnet DL, Sorensen TL.
The patient, their doctor, the regulator and the profit maker: conflicts and possible solutions.
Clin Microbiol Infect 2001; 7:

HSL18003
Holmes WF.
Conflicts of interest between the prescriber, the regulator and the profit maker.
Clin Microbiol Infect 2001; 7:

HSL18175
Fava GA
Conflict of Interest and Special Interest Groups
Psychother Psychosom 2001; 70:1-5
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowFulltext&ArtikelNr=000056218&Ausgabe=228212&ProduktNr=223864

HSL19053
Woloshin S, Schwartz LM, Moncur M, Gabriel S, Tosteson AN.
Assessing values for health: numeracy matters.
Med Decis Making 2001; 21:(5):382-90
http://www.ncbi.nlm.nih.gov/pubmed/11575488

HSL19054
Schwartz LM, Woloshin S.
The case for letting information speak for itself.
Eff Clin Pract 2001; 4:(2):76-9
http://www.acponline.org/clinical_information/journals_publications/ecp/marapr01/schwartz.htm

HSL19396
Gonul F, Carter F, Petrova E, Srinivasan K
Promotion of prescription drugs and its impact on physicians' choice behaviour
J Marketing 2001; 65: 79–90
http://www.atypon-link.com/AMA/doi/abs/10.1509/jmkg.65.3.79.18329

HSL19928
Mohr LA, Webb DJ, Harris KA
Do Consumers Expect Companies to be Socially Responsible? The Impact of Corporate Social Responsibility on Buying Behavior
Journal of Consumer Affairs 2001; 35:(1):45
http://onlinelibrary.wiley.com/doi/10.1111/j.1745-6606.2001.tb00102.x/abstract

HSL19984
Harvey R
And on the cover of the Guide were two words in red - Don't Panic
Australian Health Review 2001; 24:(2):15
http://www.publish.csiro.au/paper/AH010015.htm

HSL20109
Miller AR
Drugs: It's up to the public to complain
CMAJ 2001; 165:(1):153

HSL20178
Hoek J, Gendall P, Feetham P
Could less be more? An Analysis of Direct to Consumer Advertising of Prescription Medicines
Marketing Bulletin 2001; 12:(1):
marketing-bulletin.massey.ac.nz/V12/MB_V12_A1_Hoek.pdf

HSL20342
Dowie J
Decision analysis and the evaluation of decision technologies
BMJ 2001; 10:(1):1-2
http://qualitysafety.bmj.com/content/10/1/1

HSL2262
Nuesch R, Dieterle T.
Industry-sponsored research.
Lancet 2000 Dec 23-30; 356:(9248):2193-4
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11191572&query_hl=1

HSL2265
Halpern SD, Karlawish JH.
Industry-sponsored research. University of Pennsylvania Research Ethics Working Group.
Lancet 2000 Dec 23-30; 356:(9248):2193
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11191573&query_hl=1

HSL2620
Neusch R.
Industry-sponsored research (2nd of two letters)
Lancet 2000 Dec 23-30; 356:2193

HSL6973
Djulbegovic B, Bennett CL, Adams JR, Lyman GH.
Authors' reply
The Lancet 2000 Dec 23; 356:(9248):2193

HSL6974
Giannakakis IA, Ioannidis JP.
Arabian nights-1001 tales of how pharmaceutical companies cater to the material needs of doctors: case report.
BMJ 2000 Dec 23-30; 321:(7276):1563-4
http://www.bmj.com/cgi/content/full/321/7276/1563

HSL164
Willman D.
How a New Policy Led to Seven Deadly Drugs
The Los Angeles Times 2000 Dec 20

HSL165
Willman D.
Case Studies: Drug After Drug,Warnings Ignored Propulsid: A Heartburn Drug, Now Linked to Children's Deaths Once evidence of harm emerged, FDA took years to withdraw approval.
The Los Angeles Times 2000 Dec 20

HSL166
Willman D.
RAXAR: Warning on Label Omits Deaths Heart problems were mentioned in fine print, but not key dosage data.
The Los Angeles Times 2000 Dec 20

HSL168
Willman D.
REDUX: Unheeded warnings on Lethal Diet Pill Heart damage causes billions of dollars in potential legal liability.
The Los Angeles Times 2000 Dec 20

HSL169
Willman D.
DURACT: Painkiller Posed Risk of Damage to Liver Drugmaker's lobbying won fine print instead of prominent warning.
The Los Angeles Times 2000 Dec 20

HSL170
Willman D.
POSICOR: 143 Sudden Deaths Did Not Stop Approval With study results kept secret, nation got another blood-pressure drug.
The Los Angeles Times 2000 Dec 20

HSL171
Willman D.
LOTRONEX: Officer Foresaw Deadly Effects
The Los Angeles Times 2000 Dec 20
http://www.whale.to/drugs/lotronex.html

HSL173
Willman D.
REZULIN: Fast-Track Approval and a Slow Withdrawal Diabetes drug stayed on the market a year after being listed among the most risky.
The Los Angeles Times 2000 Dec 20

HSL175
Willman D.
RELENZA: Official Asks If One Day Less of Flu Is Worth It Still on the market, the drug has been linked to 22 deaths so far.
The Los Angeles Times 2000 Dec 20

HSL20119
Fountain B
Advertise and be damned
New Zealand Doctor 2000 Dec 202

HSL7894
Walley T, Earl-Slater A, Haycox A, Bagust A.
An integrated national pharmaceutical policy for the United Kingdom?
BMJ 2000 Dec 16; 321:(7275):1523-6
http://www.bmj.com/cgi/content/full/321/7275/1523

HSL16741
Barbehenn E, Lurie P, Wolfe SM.
Alosetron for irritable bowel syndrome.
Lancet 2000 Dec 9; 356:(9246):2009-10
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(05)72978-0

HSL20235
The Third-Person Effect
The Wager 2000 Dec 6
http://www.basisonline.org/2000/12/the-wager-vol-5.html

HSL18020
Moynihan R, Sweet M.
Medicine, the media and monetary interests: the need for transparency and professionalism.
Med J Aust 2000 Dec 4-18; 173:(11-12):631-4
http://www.mja.com.au/public/issues/173_11_041200/moynihan/moynihan.html

HSL7909
Thompson CA.
Federal drug discount program proves tricky for hospitals to navigate
American Journal of Health System Pharmacy 2000 Dec 1; 57:2130, 2134, 2139-2140

HSL213
Morgan S, Barer M, Evans R.
Health economists meet the fourth tempter: drug dependency and scientific discourse.
Health Econ 2000 Dec; 9:(8):659-67
http://www3.interscience.wiley.com/cgi-bin/abstract/76505087/ABSTRACT

HSL223
Knox KS, Adams JR, Djulbegovic B, Stinson TJ, Tomor C, Bennet CL.
Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology.
Ann Oncol 2000 Dec; 11:(12):1591-5

HSL232
Bell RA, Wilkes MS, Kravitz RL.
The educational value of consumer-targeted prescription drug print advertising.
J Fam Pract 2000 Dec; 49:(12):1092-8

HSL6972
[No authors listed]
Trial results must be accessible: Clinical research data, a public asset.
Prescrire Int. 2000 Dec; 9:(50):183

HSL7903
Richardson K, Basskin L.
Cost benefit analysis of methods used to access manufacturers' pharmaceutical assistance programs
ASHP Midyear Clinical Meeting 2000 Dec; 35:

HSL7918
Hailemeskel B, Gavgani MZ.
Assessment of accuracy and completeness of the prescription drug information on the Internet
ASHP Midyear Clinical Meeting 2000 Dec; 35:

HSL7919
Murray SG, Albano DL, Buttaro ML, Goldkamp AH.
Evaluation of health care professional satisfaction with a pharmaceutical industry's standard response letters and assessment of their impact on prescribing behavior
ASHP Midyear Clinical Meeting 2000 Dec; 35:

HSL7920
Schultz PT, Hogan TT, Clark KE.
Assessment of the impact of direct to consumer advertising of prescription drugs on consumers and prescribers
ASHP Midyear Clinical Meeting 2000 Dec; 35:

HSL20291
Messmer JJ, Parnes B, Westfall JM
Influence of pharmaceutical companies
The Journal of Family Practice 2000 Dec; 49:(12):1154
http://www.jfponline.com/Pages.asp?AID=2666

HSL206
McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, Brody BA.
A national survey of policies on disclosure of conflicts of interest in biomedical research.
N Engl J Med 2000 Nov 30; 343:(22):1621-6
http://content.nejm.org/cgi/content/abstract/343/22/1621

HSL222
Lo B, Wolf LE, Berkeley A.
Conflict-of-interest policies for investigators in clinical trials.
N Engl J Med 2000 Nov 30; 343:(22):1616-20
http://content.nejm.org/cgi/content/abstract/343/22/1616

HSL2634
Martin JB, Kasper DL.
In whose best interest? Breaching the academic-industrial wall
New England Journal of Medicine 2000 November 30; 343:(22):1646-1649
http://content.nejm.org/cgi/content/extract/343/22/1646

HSL2577
Weber W.
Merck Sharp & Dohme prosecuted for pampering Dutch doctors
Lancet 2000 Nov 25; 356:1832

HSL19753
Gilbert D, Walley T, New B
Lifestyle medicines
BMJ 2000 Nov 25; 321:1341-1344
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1119073/

HSL3678
Findlay S.
Prescription Drugs and Mass Media Advertising.
Washington, DC: National Institute of Health Care Management. 2000 Nov
http://web.archive.org/web/20080304043214/http://www.nihcm.org/publications/prescription_drugs

HSL1416
Jureidini JN.
Epidemic of schizophrenia in children or inappropriate prescribing?
Med J Aust 2000 Nov 20; 173:(10):555-6

HSL20156
Maling N
Drug advertising costs hard to swallow
Sunday Star Times 2000 Nov 19A6

HSL20144
Hall S
Direct drug advertising opposed
Australian Doctor 2000 Nov 17

HSL19535
Stolberg SG, Gerth J
High-Tech Stealth Being Used to Sway Doctor Prescriptions
The New York Times 2000 Nov 16
http://www.nytimes.com/2000/11/16/us/high-tech-stealth-being-used-to-sway-doctor-prescriptions.html

HSL19536
Petersen M.
Growing Opposition to Free Drug Samples
The New York Times 2000 Nov 15
http://www.nytimes.com/2000/11/15/business/growing-opposition-to-free-drug-samples-ultimate-costs-and-safety-are-cited.html

HSL2632
McCarthy M.
Company sought to block paper's publication
Lancet 2000 Nov 11; 356:1659

HSL2583
Summers W, Driscoll J, Orient J.
The pharmaceutical industry - to whom is it accountable? (7th of 10 letters)
New England Journal of Medicine 2000 Nov 9; 343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415

HSL2586
Schwarting J.
The pharmaceutical industry - to whom is it accountable? (3rd of 10 letters)
New England Journal of Medicine 2000 Nov 9; 343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415

HSL2587
Schwarting JS.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9; 343:(19):1416

HSL2594
Rightor N.
The pharmaceutical industry - to whom is it accountable? (6th of 10 letters)
New England Journal of Medicine 2000 Nov 9; 343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415

HSL2602
Reif M.
The pharmaceutical industry - to whom is it accountable? (2nd of 10 letters)
New England Journal of Medicine 2000 Nov 9; 343:(19):1415-6
http://content.nejm.org/cgi/content/full/343/19/1415

HSL2629
Mehta DJ.
The pharmaceutical industry - to whom is it accountable? (9th of 10 letters)
New England Journal of Medicine 2000 Nov 9; 343:(19):1417

HSL6968
Bohrer RA.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9; 343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415

HSL6969
Hayes TA.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9; 343:(19):1416
http://content.nejm.org/cgi/content/full/343/19/1415

HSL6970
Holmer AF.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9; 343:(19):1415
http://content.nejm.org/cgi/content/full/343/19/1415

HSL6971
Jacobs C.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Nov 9; 343:(19):1416-7
http://content.nejm.org/cgi/content/full/343/19/1415

HSL20097
Sweet M
Transparency with a mud-like clarity
Australian Doctor 2000 Nov 329

HSL20112
St John P
GPs hail TV ads review
Australian Doctor 2000 Nov 335

HSL2016
Biotech Firm Tries to Suppress Publication of Research: Academic Freedom at Heart of Issue
Journal of the American Medical Association 2000 Nov 1

HSL18019
Kravitz RL
Direct-to-Consumer Advertising of Prescription Drugs: Implications for the Patient-Physician Relationship
JAMA 2000 Nov 1; 284:(17):2244
http://jama.ama-assn.org/cgi/content/full/284/17/2244

HSL20366
Capozzi JD, Rhodes R
Ethics in Practice : Advertising and Marketing
The Journal of Bone and Joint Surgery 2000 Nov 1; 82:(11):1668-1668
http://jbjs.org/article.aspx?articleid=24482

HSL1855
Potdar RD.
Educating ourselves.
Indian Pediatr 2000 Nov; 37:(11):1287-8
http://www.indianpediatrics.net/nov2000/nov-1287-1288.htm

HSL3695
Rowsell LB.
Policy statement. Advertising campaigns of branded and unbranded messages.
: Therapeutic Products Directorate, Health Canada. 2000 Nov
http://www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/policy/issued/adv_campaign_e.html.

HSL7895
Wechsler J.
FDA launches debate on renewing user fees and updating FDA Modernization Act
Formulary 2000 Nov; 35:925-926

HSL7897
Pines WL.
Direct-to-consumer advertising.
Ann Pharmacother 2000 Nov; 34:(11):1341-4
http://www.theannals.com/cgi/reprint/34/11/1341

HSL20295
Lock CA, Kaner EF.
Use of marketing to disseminate brief alcohol intervention to general practitioners: promoting health care interventions to health promoters.
J Eval Clin Pract 2000 Nov; 6:(4):345-57
http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2753.2000.00268.x/abstract;jsessionid=85C526DBB3BACF2AD9AFBDBC6FACC95A.d03t04

HSL16022
Zoutman DE, Ford BD, Bassili AR.
A call for the regulation of prescription data mining
CMAJ 2000 Oct 30; 163:(9):1146
http://www.cmaj.ca/cgi/content/full/163/9/1146

HSL7038
More U.S. Children Being Diagnosed With Youthful Tendency Disorder
The Onion 2000 Oct 27

HSL7816
Tieman J.
Just roiling along.
Mod Healthc 2000 Oct 23; 30:(44):8-9

HSL16740
Wolfe S, Lurie P
Protecting Patients in Medical Research
The Washington Post 2000 Oct 17

HSL19537
Page L
More Clinics Ban Drug Samples, Citing Cost, Safety Concerns
American Medical News 2000 Oct 16
http://www.ama-assn.org/amednews/2000/10/16/bil11016.htm

HSL6967
Kiln MR, Hirst JMD.
Academia and industry
Lancet 2000 Oct 14; 356:1359

Page 140 of 144 pages ‹ First  < 138 139 140 141 142 >  Last ›